GEP20196945B - (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine - Google Patents

(r)-pirlindole and its pharmaceutically acceptable salts for use in medicine

Info

Publication number
GEP20196945B
GEP20196945B GEAP201414341A GEAP2014014341A GEP20196945B GE P20196945 B GEP20196945 B GE P20196945B GE AP201414341 A GEAP201414341 A GE AP201414341A GE AP2014014341 A GEAP2014014341 A GE AP2014014341A GE P20196945 B GEP20196945 B GE P20196945B
Authority
GE
Georgia
Prior art keywords
pirlindole
medicine
pharmaceutically acceptable
acceptable salts
pharmaceu
Prior art date
Application number
GEAP201414341A
Inventor
Sociedade Tecnico- Medicinal S.A. Tecnimede
Original Assignee
Tecnimede Sociedade Tecnico Medicinal S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal S filed Critical Tecnimede Sociedade Tecnico Medicinal S
Priority to GEAP201414341A priority Critical patent/GEP20196945B/en
Publication of GEP20196945B publication Critical patent/GEP20196945B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(R)-enantiomer of pirlindole or pharmaceu¬ti¬cally acceptable salt thereof is used in the the¬rapeutic treatment and prevention of pain. s Table: 1
GEAP201414341A 2014-05-09 2014-05-09 (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine GEP20196945B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP201414341A GEP20196945B (en) 2014-05-09 2014-05-09 (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP201414341A GEP20196945B (en) 2014-05-09 2014-05-09 (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine

Publications (1)

Publication Number Publication Date
GEP20196945B true GEP20196945B (en) 2019-02-11

Family

ID=65479047

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201414341A GEP20196945B (en) 2014-05-09 2014-05-09 (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine

Country Status (1)

Country Link
GE (1) GEP20196945B (en)

Similar Documents

Publication Publication Date Title
MX2022007221A (en) Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation.
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
MX2019015212A (en) Tinostamustine for use in treating sarcoma.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3607952A4 (en) Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors
MX2018008645A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
IL274578A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
HK1243327A1 (en) Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions
IL272495A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
ZA202006986B (en) Dantrolene formulations and methods of their use
GEP20196945B (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GEP20196946B (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
PL3813843T3 (en) Composition for use in the prevention and/or treatment of osteoarticular diseases
GB201718838D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201712742D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
TH167851B (en) (S) - Perlindole And its pharmaceutical acceptable salt for Use in medicine
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
TH167850B (en) (R) - Perlindole And its pharmacologically acceptable salt for use in medicinal drugs.
TH167851A (en) (S) - Perlindole And its pharmaceutical acceptable salt for Use in medicine